AlphaCentric Advisors’s DaVita DVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-441
Closed -$50.1K 267
2025
Q4
$50.1K Buy
+441
New +$53.6K 0.05% 241
2024
Q4
$198K Sell
1,323
-73
-5% -$11.4K 0.2% 119
2024
Q3
$229K Sell
1,396
-55
-4% -$8.13K 0.17% 124
2024
Q2
$201K Buy
1,451
+623
+75% +$85.9K 0.15% 118
2024
Q1
$114K Sell
828
-114
-12% -$13.7K 0.07% 172
2023
Q4
$98.7K Buy
+942
New +$87K 0.07% 169
2021
Q4
Sell
-1,408
Closed -$164K 235
2021
Q3
$164K Sell
1,408
-3
-0.2% -$376 0.04% 128
2021
Q2
$170K Buy
1,411
+178
+14% +$21.1K 0.05% 120
2021
Q1
$133K Sell
1,233
-42
-3% -$4.67K 0.04% 124
2020
Q4
$150K Buy
+1,275
New +$130K 0.06% 80

Other funds holding DVA

AlphaCentric Advisors's DVA Position: Q1 2026 in Review

AlphaCentric Advisors sold out of DaVita (DVA) in Q1 2026, closing a stake of 441 shares — an estimated $50.1K sold.

AlphaCentric Advisors first reported a position in DVA in Q4 2020 and held it in 10 quarters. The position peaked at $229K in Q3 2024. 582 funds tracked by Wall St. Rank hold DVA as of Q1 2026.

  • AlphaCentric Advisors reported no remaining DaVita position as of Q1 2026 after selling out during the quarter.
  • AlphaCentric Advisors sold 441 DaVita shares in Q1 2026, an estimated $50.1K.
  • AlphaCentric Advisors first reported a position in DaVita in Q4 2020 and held it in 10 quarters.
  • AlphaCentric Advisors's DaVita position peaked at $229K in Q3 2024.
  • 582 funds tracked by Wall St. Rank held DaVita as of Q1 2026.

Based on AlphaCentric Advisors's 13F filing for Q1 2026, filed 7 May 2026.